Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
4
Filing Date
1/8/2026
Updated
1/9/26, 2:01 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership